HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1862708Generated: November 1, 2026
tert-Butyl 4-oxopiperidine-1-carboxylate → HCID 21912813, compound
https://huagongshe.com/reaction/1862708
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butyl 4-oxopiperidine-1-carboxylate | HCID 735900 | — |
| Reactant | HCID 21912705 | HCID 21912705 | — |
| Reactant | HCID 178418306 | HCID 178418306 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 21912813 | HCID 21912813 | 22.5% |
Reaction Steps
To a solution of 2-ethyl-3-bromoindazole (3.4 g, 15.18 mmol) in THF (30 mL) was added t-BuLi (1.7 M in pentane, 10.72 mL, 18.22 mmol) dropwise at −78° C. After stirring at −78° C. for 20 min., was added tert-butyl 4-oxo-1-piperidinecarboxylate (3.03 g, 15.18 mmol) in THF (10 mL) dropwise at −78° C. The mixture was stirred at −78° C. for 10 min. and at rt for 18 h. After the reaction was quenched with aq. NH4Cl , the mixture was partitioned between ethyl acetate and water. The aqueous layer was extracted with ethyl acetate (3×). The combined organic phases were washed with brine, and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash chromatography (hexanes ethyl acetate=4:1, then 1:1) to give 1.18 g of the title compound as a foamy solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06538002B1 |
|---|
| Source dataset | uspto-grants-2003_03 |
|---|
| ORD ID | ord-f269ae9cf3f44386bb978edb894cba8c |
|---|
| Source note | uspto-grants-2003_03 |
|---|